神經調控設備市場按設備類型、應用、最終用戶和地區分類

Neuromodulation Devices Market, By Device Type, By Application, By End User, By Geography

出版日期: 2025年11月07日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2025 年，神經調節設備市場規模將達到 187.1 億美元，到 2032 年將達到 503.8 億美元，2025 年至 2032 年的複合年成長率為 15.2%。

報告覆蓋範圍		報告詳情
基準年：	2024	2025年市場規模：	187.1億美元
歷史數據時期：	2020年至2024年	預測期：	2025年至2032年
預測期（2025-2032年）複合年成長率：	15.20%	2032 年的預測值：	503.8億美元

神經調控裝置透過電訊號、藥物或其他能量形式刺激神經來緩解疼痛，阻斷疼痛訊號到達大腦。神經調控裝置是植入式醫療設備，透過電刺激和藥物傳遞為某些慢性疾病提供治療方案。神經調控裝置主要分為五個技術領域：脊髓刺激器、深部腦部刺激器、迷走神經刺激器、薦椎神經刺激和胃電刺激器。神經調控裝置可向神經和大腦傳送電脈衝，用於治療聽力喪失、慢性疼痛和帕金森氏症等疾病。電刺激療法利用電刺激治療脊髓損傷和與神經系統疾病相關的肌肉無力。電脈衝被激活並傳輸到神經調控裝置的電極，引起去極化，從而可能緩解疼痛並增強肌肉力量。各種類型的電刺激設備旨在治療多種疾病，包括疼痛管理和肥胖。

市場動態

預計在預測期內，監管機構對產品核可數量增加將推動全球神經調控設備市場的成長。例如，2023年4月19日，醫療科技公司BIOTRONIK宣布其Prospera脊髓刺激（SCS）系統已獲得美國食品藥物管理局（FDA）的核准。該系統採用首個多相刺激模式RESONANCE，並結合以患者為中心的Embrace One護理模式，提供自動、客觀的日常遠端監測、持續管理和支持，從而實現主動式護理。此次核准標誌著該公司新業務部門BIOTRONIK Neuro的推出。

本次調查的主要特點

本報告對全球神經調節設備市場進行了詳細分析，以 2024 年為基準年，給出了 2025 年至 2032 年的市場規模和複合年成長率 (%)。
它重點介紹了不同細分市場的潛在商機，並解釋了該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、阻礙因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
該研究根據以下參數對全球神經調控設備市場的主要企業進行了分析——公司亮點、產品系列、關鍵亮點、財務表現和策略。
本研究涵蓋的主要企業包括 Medtronic、BD、LivaNova、Axonics、ShiraTronics、Abbott、Bioventus、Neuronetics、NEVRO CORP、Integer Holdings Corporation、BIOTRONIK、NeuroPace、NeuroMetrix、Helius Medical Technologies 和 Synapse Biomedical Inc.。
本報告提供的見解將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
這份關於全球神經調控設備市場的報告將對產業內的各種相關人員有所幫助，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種用於分析全球神經調控設備市場的策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
中東
- GCC
- 以色列
- 其他中東地區
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Medtronic
BD
LivaNova
Axonics, Inc.
ShiraTronics
Abbott
Bioventus
Neuronetics
NEVRO CORP
Integer Holdings Corporation
BIOTRONIK
NeuroPace, Inc.
NeuroMetrix, Inc.
Helius Medical Technologies, Inc.
Synapse Biomedical Inc.

第9章各節

調查方法
關於出版商

簡介目錄

Product Code: CMI3861

Neuromodulation Devices Market is estimated to be valued at USD 18.71 Bn in 2025 and is expected to reach USD 50.38 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.2% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 18.71 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	15.20%	2032 Value Projection:	USD 50.38 Bn

Neuromodulation devices stimulate nerves with electrical signals, pharmaceutical agents, or other forms of energy neurostimulation that provides pain relief by blocking the transmission of pain signals before they reach the brain. Neuromodulation devices are implantable medical devices, which introduce therapeutic solutions to some chronic diseases through electric stimulation or medication. Neuromodulation devices are segmented into five major technologies, namely: spinal cord stimulation devices, deep brain stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices and gastric electric stimulation devices. Neuromodulation devices deliver electrical impulses to the nerves and the brain by treating disorders such as deafness, chronic pain, and Parkinson's disease. Lectrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has a property to activate electrical impulse and transmit signals to the electrodes of neuromodulation device, which causes depolarization and, in turn, reduces pain and improves the muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.

Market Dynamics

Increasing product approvals by regulatory authorities are expected to drive the global neuromodulation devices market growth over the forecast period. For instance, on April 19, 2023, BIOTRONIK, a medical technology company, announced the U.S. Food and Drug Administration (FDA) approval for Prospera, a Spinal Cord Stimulation (SCS) system. The system features RESONANCE, the first and multiphase stimulation paradigm, paired with Embrace One, a patient-centric care model that makes proactive care possible by offering automatic, objective, daily remote monitoring, and ongoing management and support. This approval marks the launch of the company's new business segment, BIOTRONIK Neuro.

Key features of the study

This report provides an in-depth analysis of the global neuromodulation devices market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neuromodulation devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Medtronic, BD, LivaNova, Axonics, Inc., ShiraTronics, Abbott, Bioventus, Neuronetics, NEVRO CORP, Integer Holdings Corporation, BIOTRONIK, NeuroPace, Inc., NeuroMetrix, Inc., Helius Medical Technologies, Inc., and Synapse Biomedical Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics
The global neuromodulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuromodulation devices market

Market Segmentation

Global Neuromodulation Devices Market, Device Type
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Sacral Nerve Stimulation Devices
- Vagus Nerve Stimulation Devices
- Gastric Electric Stimulation Devices
Global Neuromodulation Devices Market, Application
- Pain Management
- Neurological and Movement Disorder Management
- Musculoskeletal Disorder Management
- Metabolism and GIT Management
- Others (Incontinence Management, etc.)
Global Neuromodulation Devices Market, By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
- Others (Nursing Facilities, etc.)
Global Neuromodulation Devices Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Global Neuromodulation Devices Market Companies
- Medtronic
- BD
- LivaNova
- Axonics, Inc.
- ShiraTronics
- Abbott
- Bioventus
- Neuronetics
- NEVRO CORP
- Integer Holdings Corporation
- BIOTRONIK
- NeuroPace, Inc.
- NeuroMetrix, Inc.
- Helius Medical Technologies, Inc.
- Synapse Biomedical Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Device Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Regulatory Guidelines
Product launches
Key Development
PEST Analysis
PORTER's Analysis
Regulatory Scenario
Mergers and Acquisitions
Manufacturer Revenue
Healthcare Spending by Country

4. Global Neuromodulation Devices Market, By Device Type, 2020-2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Spinal Cord Stimulation Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Deep Brain Stimulation Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Sacral Nerve Stimulation Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Vagus Nerve Stimulation Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Gastric Electric Stimulation Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

5. Global Neuromodulation Devices Market, By Application, 2020-2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Neurological and Movement Disorder Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Musculoskeletal Disorder Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Metabolism and GIT Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others (Incontinence Management, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Neuromodulation Devices Market, By End User, 2020-2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Specialized Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others (Physiotherapy Centers, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Neuromodulation Devices Market, By Region, 2020-2032, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2020-2032, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BD
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LivaNova
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Axonics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ShiraTronics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bioventus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Neuronetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NEVRO CORP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Integer Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BIOTRONIK
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NeuroPace, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NeuroMetrix, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Helius Medical Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Synapse Biomedical Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies